HIGHLIGHTS
- who: Bakhos Jneid et al. from the Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Gif-sur-Yvette, France Editor: GTorres, University of Texas have published the article: SipD and IpaD induce a cross-protection against Shigella and Salmonella infections, in the Journal: (JOURNAL)
- what: The authors provide the first demonstration that and T3SS and promising antigens for the development of cross-protective vaccine. The results of this study show that by using indifferently SipD or IpaD, good protection (60%) against Shigella flexneri 2a infection is obtained . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.